|
Classification by platelet counts of all serious bleeding events during infusion period in all clinical trials |
||
| SBEs during infusion period |
||
|
|
||
| Platelets (×103/mm3)1 |
Events (n) |
Cumulative % |
|
|
||
| ≤ 20 |
5 |
9.4 |
| >20 to ≤ 30 |
6 |
20.8 |
| >30 to ≤ 50 |
11 |
41.5 |
| >50 to ≤ 100 |
12 |
64.2 |
| >100 |
19 |
100.0 |
| Not available |
26 |
|
| Total |
79 |
|
|
A total of 2786 patients treated with drotrecogin alfa (activated) infusion were included in this analysis. 1Platelet counts were ecorded within the preceding 24 hours of a serious bleeding event (SBE). | ||
Bernard et al. Critical Care 2003 7:155 doi:10.1186/cc2167 |
||